Author Archive | Yali Friedman

Drugs and Devices: Comparison of European and U.S. Approval Processes

This paper was originally published by Gail A.Van Norman, MD, in JACC: Basic to Translational Science Volume 1, Issue 5, August 2016, Pages 399-412 under a Creative Commons license. Summary The… The post Drugs and Devices: Comparison of European and U.S. Approval Processes appeared first on DrugPatentWatch. The post Drugs and Devices: Comparison of European and […]

Continue Reading

8 Applications of Machine Learning in The Pharmaceutical Industry

By Pankaj Mondal, DrugPatentWatch writer Machine learning, the most fundamental form of artificial intelligence, has started infiltrating the medical field, and it seems machines can play a crucial role in… The post 8 Applications of Machine Learning in The Pharmaceutical Industry appeared first on DrugPatentWatch. The post 8 Applications of Machine Learning in The Pharmaceutical […]

Continue Reading

FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals… The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared first on DrugPatentWatch. The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared […]

Continue Reading

When should you outsource drug development

For pharmaceutical companies in flux, contract services are playing a pivotal and more diverse role in the drug development process. The rapid growth of the contract research organization or CRO… The post When should you outsource drug development appeared first on DrugPatentWatch. The post When should you outsource drug development appeared first on Biotechblog.

Continue Reading

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch. The post New tentative approval for Watson Labs drug […]

Continue Reading

New patent expiration for Pf Prism drug BOSULIF

Annual Drug Patent Expirations for BOSULIF Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five… The post New patent expiration for Pf Prism drug BOSULIF appeared first on DrugPatentWatch. The post New patent expiration for Pf Prism drug BOSULIF appeared […]

Continue Reading

Which pharmaceutical drugs have the most drug patents in Austria?

This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Austria? appeared first on DrugPatentWatch. The post Which pharmaceutical drugs have the most drug […]

Continue Reading

Is importing drugs a risky affair?

The FDA was established to ensure the safety of food and medicines sold in the US. Sadly, the original charter is now slowly being affected by the advocates of drug… The post Is importing drugs a risky affair? appeared first on DrugPatentWatch. The post Is importing drugs a risky affair? appeared first on Biotechblog.

Continue Reading

New patent for Kempharm drug APADAZ

Annual Drug Patent Expirations for APADAZ Apadaz is a drug marketed by Kempharm and is included in one NDA. The generic ingredient in APADAZ is acetaminophen; benzhydrocodone hydrochloride. Additional details… The post New patent for Kempharm drug APADAZ appeared first on DrugPatentWatch. The post New patent for Kempharm drug APADAZ appeared first on Biotechblog.

Continue Reading

New patent for Novartis drug TASIGNA

Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting… The post New patent for Novartis drug TASIGNA appeared first on DrugPatentWatch. The post New patent for Novartis drug TASIGNA appeared first on Biotechblog.

Continue Reading